4.7 Letter

How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

Journal

ANNALS OF THE RHEUMATIC DISEASES
Volume 80, Issue 7, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2019-215650

Keywords

systemic lupus erythematosus; treatment; outcome measures; biologics; belimumab

Categories

Funding

  1. Swedish Research Council
  2. Professor Nanna Svartz Foundation [2017-00213, 2018-00250]
  3. Swedish Rheumatism Association
  4. King Gustaf V's 80-year Foundation
  5. Stockholm County Council
  6. Karolinska Institutet Foundations
  7. NHMRC Career Development Fellowship [APP1126370]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available